The Priority Review

Clinical trials Brief

Results posted for TAK-881 PK, safety study in primary immunodeficiency diseases

Results for this study were first posted on ClinicalTrials.gov on September 30, 2026. The study enrolled 65 participants and completed primary data collection on January 20, 2026.

Primary source

ClinicalTrials.gov results record, September 30, 2026

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Read the source: A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation